Recap: Elanco Animal Health Q4 Earnings
Shares of Elanco Animal Health (NYSE:ELAN) moved higher by 3.7% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share decreased 47.83% over the past year to $0.12, which beat the estimate of $0.09.
Revenue of $1,139,700,000 higher by 44.82% year over year, which beat the estimate of $1,060,000,000.
Outlook
Elanco Animal Health sees Q1 adjusted EPS of $0.20-$0.25.
Details Of The Call
Date: Feb 24, 2021
Time: 08:00 AM
Technicals
52-week high: $34.09
Company's 52-week low was at $15.17
Price action over last quarter: Up 3.03%
Company Overview
Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Latin America, and the Asia Pacific with the highest revenue from the North America segment. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
